Top Markets
Coin of the day
GBS Inc. GBS Inc.

GBS Inc.

GBS
Rang în acțiuni #33717
Operating across North America and the Asia-Pacific region, GBS Inc.... Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Preț acțiune
$0.4732
Ultima sincronizare: 2022-10-26
Capitalizare de piață
$7.05M
Schimbare (1 zi)
-0.03%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează GBS Inc. (GBS)

Categorie

Istoric al prețului acțiunii pentru GBS Inc. (GBS)
Cel mai mare preț de închidere: $0.49 pe 2022-10-01

Cel mai mic preț de închidere: $9.14 pe 2020-12-01
Istoric al prețului acțiunii pentru GBS Inc. din 2020 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2022 -69.81%
2021 -82.27%
2020 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US